Standard Bariatrics receives FDA indication for #1 bariatric surgical procedure

(CincyTech) Standard Bariatrics, an innovator of surgical devices, has received a sleeve gastrectomy indication from the Food and Drug Administration (FDA) for the STANDARD CLAMP ® . " Standard Bariatrics is committed to creating superior bariatric surgery outcomes through device innovations. The acceptance of the supplemental data by the FDA to expand the US. indications of the STANDARD CLAMP ® is another significant milestone for the Company, " said Jonathan Thompson M.D., Founder and Chief Medical Officer of Standard Bariatrics.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news

Related Links:

Leaks and fistulas after laparoscopic sleeve gastrectomy (SG) are a major adverse event of bariatric surgery. Endoscopic management for post SG leaks has evolved from closure with covered self-expanding metallic stents (SEMS) to endoscopic internal drainage (EID).
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: Original articles Source Type: research
ConclusionMorbidly obese ESKD patients have an equal weight loss to patients without ESKD. Bariatric surgery could improve access to kidney transplantation and may potentially improve transplantation outcomes of obese patients with ESKD.
Source: Obesity Surgery - Category: Surgery Source Type: research
Gastroesophageal Reflux Disease (GERD), including erosive esophagitis, is highly prevalent in the obese population. Laparoscopic Sleeve Gastrectomy (LSG) is one of the most frequently performed bariatric procedures. The relationship between LSG and GERD has gained increasing attention. This retrospective study aims to assess the effectiveness of combined LSG and modified Rossetti anti-reflux fundoplication for the treatment of GERD on morbidly obese patients after bariatric surgery.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: Original articles Source Type: research
Conclusions: Stone or sludge development in the gallbladder due to rapid weight loss after obesity surgery is quite common. However, we observed that the gallstone development decreased significantly with the prophylactic use of UDCA in patients who had undergone obesity surgery. PMID: 32233269 [PubMed - in process]
Source: Acta Gastro-Enterologica Belgica - Category: Gastroenterology Tags: Acta Gastroenterol Belg Source Type: research
AbstractIntroductionBone mineral density (BMD) declines in the initial years after bariatric surgery, but long-term skeletal effects are unclear and comparisons between sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are rare.Design and MethodsAn observational longitudinal study of obese patients undergoing SG or RYGB was performed. Whole-body (WB) BMD, along with BMD of the total hip (TH), femoral neck (FN), and lumbar spine (LS), was measured by dual-energy X-ray absorptiometry (DXA) before surgery and yearly thereafter for 4  years. Calciotropic hormones were also measured.ResultsForty-seven patients un...
Source: Obesity Surgery - Category: Surgery Source Type: research
ConclusionsSuper morbidly obese patients required fewer opioids and analgesics perioperatively. They exhibited higher comorbidities with greater anaesthesia time and ICU admissions. PACU stay time and pain scores were comparable.
Source: Obesity Surgery - Category: Surgery Source Type: research
ConclusionsThis is the first report of cognitive improvements following VSG and the first direct comparison of cognitive improvements following RYGB and VSG. Short-term improvements in specific domains of cognitive function are observed at the beginning of the active weight loss phase following bariatric surgery that persisted to 3  months. The anatomical distinction between the two surgeries and resulting differential metabolic profiles may be responsible for the improvements in attention observed following RYGB but not following VSG.
Source: Surgical Endoscopy - Category: Surgery Source Type: research
AbstractBackgroundEnhanced recovery after surgery (ERAS) protocols have been extensively proven in lower gastrointestinal surgery to decrease postoperative physiologic stress and length of stay (LOS). ERAS in bariatric surgery (ERABS) varies immensely from each program with inconsistent results with a predominant goal of reducing LOS. Our focus in implementing enhanced recovery after bariatric surgery (ERABS) protocols is aimed at reducing postoperative pain and opioid use.MethodsThis is a retrospective review of patients who underwent laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (VSG) at a single hig...
Source: Surgical Endoscopy - Category: Surgery Source Type: research
Patients with left ventricular assist devices (LVADs) who are morbidly obese cannot be easily bridged to heart transplantation (HT). Reported UNOS data show that the survival rate of such patients was low after HT. Some patients are obese at the time of LVAD implantation, whereas others become morbidly obese following LVAD implantation. We applied laparoscopic sleeve gastrectomy (LSG) as a treatment strategy and our study looked to determine its efficacy and safety.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: (835) Source Type: research
Abstract The worldwide obesity epidemic has led to an increase in the number of bariatric procedures for treatment. Currently, the most commonly performed bariatric surgical operation in the United States is the laparoscopic sleeve gastrectomy (LSG). The risk of postoperative nausea and vomiting (PONV) is exceptionally high following the LSG: as much as 65%. Anesthesia providers should be mindful of this elevated risk and stay up to date on evidence-based techniques that help to mitigate the incidence of PONV related to this specific procedure. The purposes of this clinical review are to increase provider awarenes...
Source: AANA Journal - Category: Anesthesiology Authors: Tags: AANA J Source Type: research
More News: Bariatric Surgery | Food and Drug Administration (FDA) | Gastrectomy | Gastroenterology